INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
3,564,641
Share change
+133,772
Total reported value
$88,336,000
Price per share
$24.78
Number of holders
25
Value change
+$3,417,203
Number of buys
17
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q3 2020

As of 30 Sep 2020, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,564,641 shares. The largest 10 holders included NEW YORK LIFE INVESTMENT MANAGEMENT LLC, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, MORGAN STANLEY, ENVESTNET ASSET MANAGEMENT INC, GeoWealth Management, LLC, BANK OF AMERICA CORP /DE/, AE Wealth Management LLC, Strategic Investment Advisors / MI, and Sawtooth Solutions, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.